Ligand’s OmniAb® platforms – OmniRat®, OmniMouse® and OmniFlic® – are based on novel, transgenic rodents that produce highly diversified antibody repertoires and offer accelerated discovery of fully human antibodies that are naturally optimized in vivo for manufacturability, therapeutic efficacy and reduced immunogenicity – Naturally optimized human antibodies®. The three platforms use patented technology, have broad freedom to operate, and deliver fully human antibodies with high affinity, specificity, expression, solubility and stability.
Applied BioMath applies mechanistic modeling to drug R&D to help biotechnology and pharmaceutical companies answer questions and make decisions for the advancement of drug candidates. A team of mathematicians, biologists, clinical pharmacologists and pharmaceutical industry experts, they leverage biology, mathematics, proprietary technologies, HPC, and industry experience to perform massive scale simulations which enable groups to determine best-in-class properties of a clinical candidate, reduce attrition rates, and identify key differentiators from competitors. www.appliedbiomath.com